In vitro preparation of cells with high development potential, useful as implants for treating nerve degeneration, comprises inducing mitogen-activated protein kinase-activated protein kinase
DE10114682A1
Use of raf to inhibit bacterial porin factors
DE10110350A1
New nucleic acid encoding part of a mitogenic protein kinase, useful for treating e.g. acquired immune deficiency syndrome and for drug screening, also related peptide
DE10029131A1
New nucleic acid encoding protein kinase of the mitogenic signaling pathway, useful for identifying cytostatic agents, includes the sequence of a glycolytic enzyme binding site
DE10020138A1
Nucleic acid coding for at least one partial sequence with a MEKK1 binding site
DE19754774A1
Transgenic non-human mammal with an oncogenic mutant of the Raf-1 gene
